PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

46 hedge funds and large institutions have $121M invested in VanEck Pharmaceutical ETF in 2020 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 11 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
46
Holders Change
-1
Holders Change %
-2.13%
% of All Funds
0.93%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
5
Increased
11
Reduced
11
Closed
6
Calls
$361K
Puts
$24.3M
Net Calls
-$24M
Net Calls Change
-$23.7M

Top Buyers

1
Bank of America
Bank of America
North Carolina
+$31.1M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.83M
3
Citadel Advisors
Citadel Advisors
Florida
+$1.59M
4
IMC Chicago
IMC Chicago
Illinois
+$1.35M
5
DI
DFPG Investments
Utah
+$703K

Top Sellers

1
BCI
Brinker Capital Investments
Pennsylvania
-$4.97M
2
Goldman Sachs
Goldman Sachs
New York
-$2.76M
3
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
-$1.37M
4
TRCT
Tower Research Capital (TRC)
New York
-$807K
5
OPS
Orion Portfolio Solutions
Nebraska
-$595K
Name Holding Trade Value Shares
Change 		Shares
Change %
CAN
51
Cetera Advisor Networks
California
– -$12K -200 Closed
FANJ
52
Financial Architects (New Jersey)
New Jersey
– -$5K -74 Closed
1 2
3